Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC-Derived Exosomes for Radiation-Induced Xerostomia in Nasopharyngeal Carcinoma
ChiCTR2500107372Phase 2Not yet recruiting
- Sponsor
- Fujian Medical University Union Hospital
- Start
- Jan 2026
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mesenchymal stem cell exosomes in xerostomia, sponsored by Fujian Medical University Union Hospital. Primary endpoint: Variation level of salivary secretion flow rate at rest and under stimulation. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
mesenchymal stem cell exosomes
03
Conditions
xerostomia
Beyond the preview
Go deeper on ChiCTR2500107372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107372.